Forensic and Pharmaceutical, Criminal and Legal, Social and Economic Study of the Conditions, that Cause Bribery Corruption in the System of Legal Relations "Doctor-Patient-Investigator-Lawyer"

Data from the scientific literature on the current state of the spread of dependence on psychoactive substances of plant origin – cannabinoids was processed. The problem of cannabinoid addiction has been studied. Forensic and pharmaceutical practice was analyzed. The development of organizational measures in order to provide drug patients with cannabinoid addiction (F12) with a comprehensive approach was substantiated. The peculiarities of pharmacotherapy and the availability of drugs for drug addicts have been clarified. The methods of assessing the availability and effectiveness of hepatoprotectors based on pharmacoeconomic, forensic and pharmaceutical indicators have been improved.

Section: Fig 2 Histogram Of the Distribution Of The Effectiveness Of ...mentioning

confidence: 99%

Cannabinoid Addiction: Pharmacotherapy, Forensic and Pharmaceutical Practice, Availability of Drugs

Осинцева

2023

“…The transformation of Ukrainian society to the civilized forms and democratic institutions of the EU is accompanied by the formation of a transparent legal field, promotes the protection of rights and freedoms, will, health and life of citizens, patients, pharmacists, and doctors. Pharmaceutical and medical law is considered as a social institution and a means of implementing legal, political-economic, social, and moral-ethical goals in the health care system [122][123][124][125].…”

Section: Immunization Practice Standards For Children and Adolescentsmentioning

confidence: 99%

Forensic and Pharmaceutical Risks in the Organization of Pharmacotherapy of Covid, Post-Covid and Long-Covid Disorders. COVID-19 and Vaccination Practice Standards.

Шаповалова

2022

The COVID-19 pandemic has strained the healthcare system. It is important to consider forensic and pharmaceutical risks in the organization of vaccination practices and pharmacotherapy of covid, post-covid and long-covid disorders. Scientific sources on the clinical characteristics of SARS-CoV-2, COVID-19 have been systematized. The standards of vaccination practice (immunization, vaccination) of different age categories of the population in Ukraine, England, USA, Belgium, Greece, Japan, and Portugal were analyzed. Proven that the organization of pharmacotherapy schemes is difficult due to the presence of mixed infections, comorbid and complicated forms of diseases, the formation of virus resistance to drugs, and the development of secondary immunological insufficiency. The risks of pharmacotherapy with regard to mortality in patients with COVID-19 due to the development of severe lung lesions and systemic multiorgan pathology are indicated. Schemes of combined pharmacotherapy including antiviral, anti-inflammatory drugs, glucocorticosteroids, genetically engineered biological drugs and "targeted" basic anti-inflammatory drugs were analyzed. The theoretical prerequisites for "repositioning" (drug repurposing) for the treatment of COVID-19 and ego complications are indicated. New directions of anti-inflammatory pharmacotherapy of COVID-19 Janus kinase with a range of anti-inflammatory and antiviral effects were noted. Emphasis was placed on the importance of informing health care professionals about forensic pharmaceutical risks in pharmacotherapy and vaccination practices. The relevance of legal support for medical activity in the conditions of a pandemic was noted. Further research is ongoing.

“…Ketamine became the first non-inhalation anesthetic. The drug was used in psychiatric and other scientific studies [30][31][32][33].…”

mentioning

confidence: 99%

Clinical and Pharmacological, Organizational and Legal, Forensic and Pharmaceutical Research of Drugs of ATC-Group N01AX03 for Anesthesia

Осинцева

2023

Clinical and pharmacological, organizational and legal, forensic and pharmaceutical study of drugs of the N01AX03 group for anesthesia was conducted. A clinical and pharmacological research based on the results of a documentary analysis in a retrospective measurement of indicators of clinical-pharmaceutical safety of ketamine showed that ketamine became the first non-inhalation anesthetic. It causes dissociative anesthesia with an analgesic effect. It is used in emergency surgery, during evacuation in combat conditions, in cardiac surgery, dentistry, ophthalmology, otorhinolaryngology, gynecology. It is prescribed for patients with traumatic shock and blood loss. The organizational and legal research based on the results of the study of the marketing, classification, legal, nomenclature and legal indicators of drugs with ATC code N01AX03 showed the circulation on the pharmaceutical market of Ukraine of 4fourpsychotropic, prescription drugs of ketamine in the form of ampoules and vials for intramuscular and intravenous administration. Forensic and pharmaceutical research based on the results of the study of the control regime, availability, cases from forensic pharmaceutical practice, legal responsibility for the illegal circulation of drugs with ATS code N01AX03 made it possible to establish a direct relationship between the indicated indicators.